PAREXEL International (United Kingdom)

PAREXEL International (United Kingdom)

Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for PAREXEL International (United Kingdom), United Kingdom, covering academic research published from 2001 to 2021. Read More.


Open Access Percentage

61%


Total
Publications

683


Total Open
Publications

418


Total
Citations

12k


Open Access
Percentage

61%


Total
Publications

683


Total Open
Publications

418


Total
Citations

12k

Wikipedia

Website

Download

Embed

United KingdomCompany

Breakdown

return ()

Publisher Open

27%

Both

29%

Other Platform Open

5%

Closed

39%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Open

Closed

Publisher Open

28%OA Journal

OA Journal 28%

109

Hybrid 53%

203

No Guarantees 19%

71

Other Platform Open

Domain 93%

213

Institution 28%

64

Public 15%

35

Preprint 3%

6

Other Internet 1%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
214
Europe PMC
Domain
167
Semantic Scholar
Public
30
University College London - UCL Discovery
Institution
20
Figshare
Public
7
University of Oxford - Oxford University Research Archive (ORA)
Institution
5
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
5
University of Birmingham - University of Birmingham Research Portal
Institution
4
MDPI
Preprint
4
Ghent University - Ghent University Academic Bibliography
Institution
4
1 / 8

Data updated 27 September 2022

Share

Share

Share